Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.467
Neutral
RSI(14)
60.263
Neutral
STOCH(KDJ)(9,3,3)
49.437
Neutral
ATR(14)
0.315
High Vlolatility
CCI(14)
-36.183
Neutral
Williams %R
58.824
Sell
TRIX(12,20)
0.018
Sell
StochRSI(14)
0.000
Sell
Search
Masimo Corp
MASIAdd to Watchlist
178.400USD
-0.150-0.08%
Close 05/13, 16:00（ET）Quotes delayed by 15 min
9.35BMarket Cap
124.89P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Masimo Corp
Currency: USD Updated: 2026-05-12Key Insights
Masimo Corp's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 96 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 176.75.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Masimo Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Masimo Corp Highlights
StrengthsRisks
Masimo Corporation is a global medical technology company that develops and produces a wide range of monitoring technologies, including measurements, sensors, patient monitors, automation and connectivity solutions. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. It primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry, and advanced rainbow Pulse CO-Oximetry parameters such as noninvasive hemoglobin (SpHb), alongside many other modalities, including brain function monitoring, hemodynamic monitoring, regional oximetry, capnography and gas monitoring, and others.
Overvalued
The company’s latest PE is 124.99, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 57.76M shares, decreasing 8.83% quarter-over-quarter.
Held by Joel Greenblatt
Star Investor Joel Greenblatt holds 342.19K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.09.
Analyst Rating
Based on
9
analysts
Hold
Current Rating
176.750
Target Price
-0.87%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Health
Currency: USD Updated: 2026-05-12The current financial score of Masimo Corp is 7.34, ranking 76 out of 206 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 403.60M, representing a year-over-year increase of 8.49%, while its net profit experienced a year-over-year increase of 133.45%.
Score
Financials
7.42
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
7.55
Operational Efficiency
7.24
Growth Potential
7.35
Shareholder Returns
7.14
Masimo Corp's Company Valuation
Currency: USD Updated: 2026-05-12The current valuation score of Masimo Corp is 6.81, ranking 143 out of 206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 124.99, which is 0.00% below the recent high of 124.99 and 150.59% above the recent low of -63.23.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 96/206
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2026-05-12The current earnings forecast score of Masimo Corp is 6.22, ranking 170 out of 206 in the Healthcare Equipment & Supplies industry. The average price target is 180.00, with a high of 210.00 and a low of 162.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
9
analysts
Hold
Current Rating
176.750
Target Price
-0.98%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
116
Total
6
Median
9
Average
Company name
Ratings
Analysts
Masimo Corp
MASI
9
Medtronic PLC
MDT
33
Stryker Corp
SYK
32
Abbott Laboratories
ABT
31
Dexcom Inc
DXCM
31
Zimmer Biomet Holdings Inc
ZBH
30
1
2
3
...
23
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2026-05-12The current price momentum score of Masimo Corp is 3.69, ranking 193 out of 206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 178.82 and the support level at 178.22, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
178.454
Sell
MA10
178.445
Sell
MA20
178.476
Sell
MA50
177.719
Buy
MA100
161.270
Buy
MA200
153.464
Buy
Institutional Confidence
Currency: USD Updated: 2026-05-12Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Risk Assessment
Currency: USD Updated: 2026-05-12The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Masimo Corp is 7.81, ranking 28 out of 206 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.12. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.
Score
Beta vs S&P 500 index
1.13
VaR
+3.87%
240-Day Maximum Drawdown
+25.92%
240-Day Volatility
+44.16%
Return
Best Daily Return
60 days
+34.22%
120 days
+34.22%
5 years
+34.22%
Worst Daily Return
60 days
-2.11%
120 days
-4.82%
5 years
-36.99%
Sharpe Ratio
60 days
+2.03
120 days
+0.87
5 years
+0.04
Risk Assessment
Maximum Drawdown
240 days
+25.92%
3 years
+53.67%
5 years
+74.70%
Return-to-Drawdown Ratio
240 days
+0.59
3 years
+0.07
5 years
-0.09
Skewness
240 days
+6.75
3 years
+2.16
5 years
-0.55
Volatility
Realised Volatility
240 days
+44.16%
5 years
+47.27%
Standardised True Range
240 days
+2.19%
5 years
+2.92%
Downside Risk-Adjusted Return
120 days
+286.96%
240 days
+286.96%
Maximum Daily Upside Volatility
60 days
+70.75%
Maximum Daily Downside Volatility
60 days
+69.89%
Liquidity
Average Turnover Rate
60 days
+3.11%
120 days
+2.25%
5 years
--
Turnover Deviation
20 days
-8.69%
60 days
+109.39%
120 days
+51.58%
Peer Comparison
Healthcare Equipment & Supplies
Masimo Corp
MASI
6.62 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
LNTH
8.76 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Anika Therapeutics Inc
ANIK
8.57 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
LivaNova PLC
LIVN
8.42 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Thermo Fisher Scientific Inc
TMO
8.39 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Bruker Corp
BRKR
8.30 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
